Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.153,00
-1,08%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TenX Keane Acquisition (TENK) TenX Keane Acquisition (TENK) Notizie

TENK

TenX Keane Acquisition (TENK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TENK
DataOraFonteTitoloSimboloCompagnia
09/08/202413:30GlobeNewswire Inc.TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market UpdateNASDAQ:TENKTenX Keane Acquisition
05/08/202414:00PR Newswire (US)Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.NASDAQ:TENKTenX Keane Acquisition
05/08/202414:00GlobeNewswire Inc.TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius PharmaceuticalsNASDAQ:TENKTenX Keane Acquisition
10/07/202415:10PR Newswire (US)Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage CandidatesNASDAQ:TENKTenX Keane Acquisition
10/01/202420:29GlobeNewswire Inc.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalNASDAQ:TENKTenX Keane Acquisition
24/10/202313:30GlobeNewswire Inc.Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKTenX Keane Acquisition
18/10/202322:00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKTenX Keane Acquisition
15/05/202322:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TENKTenX Keane Acquisition
31/03/202322:33Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TENKTenX Keane Acquisition
14/02/202321:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKTenX Keane Acquisition
10/02/202322:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TENKTenX Keane Acquisition
06/12/202222:58GlobeNewswire Inc.TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022NASDAQ:TENKTenX Keane Acquisition
18/10/202220:20GlobeNewswire Inc.TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment OptionNASDAQ:TENKTenX Keane Acquisition
14/10/202200:00GlobeNewswire Inc.TenX Keane Acquisition Announces Pricing of $60 Million Initial Public OfferingNASDAQ:TENKTenX Keane Acquisition
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TENK

La tua Cronologia

BIT
S28287
Societe Generale Effekten
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network